ras oncogene product p21 expression and prognosis of human ovarian tumors
- 1 July 1992
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 46 (1) , 45-50
- https://doi.org/10.1016/0090-8258(92)90194-n
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Immunohistochemical Study of ras p21 Expression in Human Gastric Cancers and Benign LesionsOncology, 1989
- Prognostic implications of expression of the cellular genes myc, fos, Ha‐ras and Ki‐ras in colon carcinomaInternational Journal of Cancer, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- The Oncogenic Activation of Human p21
ras
by a Novel MechanismScience, 1986
- Expression ofrasOncogene p21 in Prostate CancerNew England Journal of Medicine, 1986
- Biological and biochemical properties of human rasH genes mutated at codon 61Cell, 1986
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985
- ras Oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma.The Journal of Experimental Medicine, 1985
- Expression of Cellular Oncogenes in Human MalignanciesScience, 1984
- Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virusNature, 1982